Living Proof Leases Entire Floor at Brick-and-Beam Property in Seaport District

Why It Matters

The lease underscores growing demand for flexible, lab‑ready office space in Boston’s biotech hub, signaling confidence in the Seaport’s emerging life‑science ecosystem. It also validates P3RE’s strategy of repurposing historic structures to meet specialized tenant needs.

Key Takeaways

• Living Proof signed 14,085 sq ft lease on fifth floor.
• Lease covers office and lab space in GENESIS 12 Farnsworth.
• Property conversion preserves historic character while adding modern labs.
• P3RE’s ready‑spec space aims to attract life‑science tenants.

Pulse Analysis

Boston’s Seaport District has evolved from a commercial‑real‑estate playground into a magnet for life‑science firms seeking proximity to research institutions and a vibrant talent pool. Developers are re‑imagining legacy office blocks, installing high‑spec lab infrastructure while preserving historic façades, to meet the sector’s demand for turnkey environments. This trend reflects a broader shift where biotech companies favor flexible, ready‑to‑use spaces over building custom labs from scratch, accelerating time‑to‑market.

Living Proof, known for its innovative hair‑care technologies, is relocating from the Innovation & Design Building to a 14,085‑square‑foot floor that blends office workstations with state‑of‑the‑art laboratories. The move positions the company within a cluster of peers, fostering collaboration and easier access to specialized service providers. By consolidating its operations under one roof, Living Proof can streamline R&D workflows, reduce overhead associated with disparate locations, and capitalize on the Seaport’s robust transportation links.

For real‑estate investors, the transaction validates Phase 3 Real Estate Partners’ model of converting historic structures into life‑science hubs. The ready‑spec approach reduces leasing friction, allowing tenants like Living Proof to focus on growth rather than fit‑out timelines. CBRE’s involvement on both sides highlights the brokerage’s deep expertise in niche biotech leasing, a service increasingly prized as the industry expands. As more firms chase similar efficiencies, expect a surge in adaptive‑reuse projects that blend heritage preservation with cutting‑edge lab capabilities.